Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Titus

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infectionR V Morris, C B Shoemaker, J R David, et al.
American Journal of Epidemiology|March 1, 1996
Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureusJ A Jernigan, M G Titus, D H Gröschel, et al.
Plos One|November 5, 2010
BluePort: a platform to study the eosinophilic response of mice to the bite of a vector of Leishmania parasites, Lutzomyia longipalpis sand fliesJ Santiago Mejia, Amanda L Toot-Zimmer, Patricia C Schultheiss, et al.
The American Journal of Tropical Medicine and Hygiene|September 14, 2006
Salivary gland extracts of Culicoides sonorensis inhibit murine lymphocyte proliferation and no production by macrophagesJeanette V Bishop, J Santiago Mejia, Adalberto A Pérez de León, et al.
Sub-Cellular Biochemistry|January 1, 1992
Role of T cells in immunity to the intracellular pathogen, Leishmania majorR G Titus, C M Theodos, P B Kimsey, et al.
European Journal of Immunology|March 1, 1991
Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivityR G Titus, I Müller, P Kimsey, et al.
FEMS Microbiology Letters|May 15, 2002
Type 1 and type 2 responses to Leishmania majorKathleen A Rogers, Gregory K DeKrey, M Lamine Mbow, et al.
Infection and Immunity|July 24, 2004
Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. majorCynthia M Theodos, Robin V Morris, Jeanette V Bishop, et al.
The Journal of Infectious Diseases|May 1, 1995
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the diseaseH R Chakkalath, C M Theodos, J S Markowitz, et al.
Vaccine|October 29, 2017
Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine modelWilliam H Wheat, Erik N Arthun, John S Spencer, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infectionR V Morris, C B Shoemaker, J R David, et al.
American Journal of Epidemiology|March 1, 1996
Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureusJ A Jernigan, M G Titus, D H Gröschel, et al.
Plos One|November 5, 2010
BluePort: a platform to study the eosinophilic response of mice to the bite of a vector of Leishmania parasites, Lutzomyia longipalpis sand fliesJ Santiago Mejia, Amanda L Toot-Zimmer, Patricia C Schultheiss, et al.
The American Journal of Tropical Medicine and Hygiene|September 14, 2006
Salivary gland extracts of Culicoides sonorensis inhibit murine lymphocyte proliferation and no production by macrophagesJeanette V Bishop, J Santiago Mejia, Adalberto A Pérez de León, et al.
Sub-Cellular Biochemistry|January 1, 1992
Role of T cells in immunity to the intracellular pathogen, Leishmania majorR G Titus, C M Theodos, P B Kimsey, et al.
European Journal of Immunology|March 1, 1991
Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivityR G Titus, I Müller, P Kimsey, et al.
FEMS Microbiology Letters|May 15, 2002
Type 1 and type 2 responses to Leishmania majorKathleen A Rogers, Gregory K DeKrey, M Lamine Mbow, et al.
Infection and Immunity|July 24, 2004
Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. majorCynthia M Theodos, Robin V Morris, Jeanette V Bishop, et al.
The Journal of Infectious Diseases|May 1, 1995
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the diseaseH R Chakkalath, C M Theodos, J S Markowitz, et al.
Vaccine|October 29, 2017
Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine modelWilliam H Wheat, Erik N Arthun, John S Spencer, et al.
Pageof 14